Результати пошуку - Marc Ferrante
- Показ 1 - 20 результатів із 125
- На наступну сторінку
-
1
New biologics and small molecules in inflammatory bowel disease: an update за авторством João Sabino, Bram Verstockt, Séverine Vermeire, Marc Ferrante
Опубліковано 2019Revisão -
2
Organoid-based Models to Study the Role of Host-microbiota Interactions in IBD за авторством Martina Poletti, Kaline Arnauts, Marc Ferrante, Tamás Korcsmáros
Опубліковано 2020Revisão -
3
New treatment options for inflammatory bowel diseases за авторством Bram Verstockt, Marc Ferrante, Séverine Vermeire, Gert Van Assche
Опубліковано 2018Revisão -
4
Sarcoidosis-Like Lesions: Another Paradoxical Reaction to Anti-TNF Therapy? за авторством Amelie Decock, Gert Van Assche, Séverine Vermeire, Wim Wuyts, Marc Ferrante
Опубліковано 2016Revisão -
5
-
6
Predictive Model for the Outcome of Infliximab Therapy in Crohnʼs Disease Based on Apoptotic Pharmacogenetic Index and Clinical Predictors за авторством Tibor Hlavatý, Marc Ferrante, Liesbet Henckaerts, Rajaraman Eri, Paul Rutgeerts, Séverine Vermeire
Опубліковано 2006Artigo -
7
-
8
Tofacitinib concentrations in plasma and breastmilk of a lactating woman with ulcerative colitis за авторством Mette Julsgaard, Uma Mahadevan, Thea Vestergaard, Raf Mols, Marc Ferrante, Patrick Augustijns
Опубліковано 2023Carta -
9
-
10
-
11
-
12
-
13
Understanding the Molecular Drivers of Disease Heterogeneity in Crohn’s Disease Using Multi-omic Data Integration and Network Analysis за авторством Padhmanand Sudhakar, Bram Verstockt, Jonathan Cremer, Sare Verstockt, João Sabino, Marc Ferrante, Séverine Vermeire
Опубліковано 2020Artigo -
14
Prognostic factors for long‐term infliximab treatment in Crohn's disease patients: a 20‐year single centre experience за авторством Thomas Billiet, Isabelle Cleynen, Vera Ballet, Marc Ferrante, Gert Van Assche, Ann Gils, Séverine Vermeire
Опубліковано 2016Artigo -
15
-
16
Higher Infliximab Trough Levels Are Associated With Better Outcome in Paediatric Patients With Inflammatory Bowel Disease за авторством Karen van Hoeve, Erwin Dreesen, Ilse Hoffman, Gert Van Assche, Marc Ferrante, Ann Gils, Séverine Vermeire
Опубліковано 2018Artigo -
17
-
18
DOP22 Integrative -omic analysis reveals microbiota mediated molecular mechanisms influencing host mucosal gene expression in Crohn’s Disease за авторством Padhmanand Sudhakar, Tahila Andrighetti, Sare Verstockt, Clara Caenepeel, Marc Ferrante, João Sabino, Bram Verstockt, Séverine Vermeire
Опубліковано 2021Artigo -
19
Integrated analysis of microbe-host interactions in Crohn’s disease reveals potential mechanisms of microbial proteins on host gene expression за авторством Padhmanand Sudhakar, Tahila Andrighetti, Sare Verstockt, Clara Caenepeel, Marc Ferrante, João Sabino, Bram Verstockt, Séverine Vermeire
Опубліковано 2022Artigo -
20
Post-Induction Adalimumab Concentration is Associated with Short-Term Mucosal Healing in Patients with Ulcerative Colitis за авторством Konstantinos Papamichael, Filip Baert, Sophie Tops, Gert Van Assche, Paul Rutgeerts, Séverine Vermeire, Ann Gils, Marc Ferrante
Опубліковано 2016Artigo
Інструменти для пошуку:
Пов'язані теми
Medicine
Internal medicine
Disease
Gastroenterology
Ulcerative colitis
Crohn's disease
Inflammatory bowel disease
Biology
Surgery
Infliximab
Immunology
Tumor necrosis factor alpha
Genetics
Adalimumab
Gene
Pathology
Physics
Biochemistry
Intensive care medicine
Vedolizumab
Chemotherapy
Colitis
Interquartile range
Retrospective cohort study
Cancer
Cell biology
Endoscopy
Odds ratio
Adverse effect
Confidence interval